Write For Us

Sinovac's vaccine 'attractive option,' study finds

Sponsored Post Vitamin D2 Canada Persia
92 Views
Published
Sinovac’s experimental COVID-19 vaccine triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed.


Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, business, finance
Sign in or sign up to post comments.
Be the first to comment